サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1543928

骨髄内注入装置の世界市場

Intraosseous Infusion Devices

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
骨髄内注入装置の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

骨髄内注入装置の世界市場は2030年までに82億米ドルに到達

2023年に54億米ドルと推定される骨髄内注入装置の世界市場は、2023年から2030年にかけてCAGR 6.3%で成長し、2030年には82億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである自動技術は、CAGR 7.5%を記録し、分析期間終了時には56億米ドルに達すると予測されます。手動技術セグメントの成長率は、分析期間中CAGR 4.3％と推定されます。

米国市場は15億米ドルと推定、中国はCAGR 5.8％で成長予測

米国の骨髄内注入装置市場は2023年に15億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.1%と4.9%と予測されています。欧州では、ドイツがCAGR 5.0%で成長すると予測されています。

世界の骨髄内注入装置市場- 主要動向と促進要因のまとめ

骨髄内注入装置とは何か、なぜ救急医療に不可欠なのか？

骨髄内注入装置は、従来の静脈内（IV）アクセスが不可能な場合に、輸液、投薬、血液製剤を骨髄に直接投与するために設計された特殊な医療器具です。これらの器具は救急医療、特に外傷、心停止、ショック時など、一刻を争うような状況において重要であり、患者は静脈が潰れていたり、静脈へのアクセスが困難な他の状態にある場合があります。静脈内注入は、迅速で、信頼性が高く、効果的なバスキュラーアクセスの代替手段を提供し、救命治療を迅速に行えるようにします。このようなデバイスの使用は、特に緊急治療室、集中治療室、軍隊など、即座の血管アクセスが患者の転帰に大きな影響を与える場面で増加しています。

技術の進歩は骨髄内注入装置市場をどのように形成しているか？

技術の進歩は、骨髄内注入装置市場の形成に重要な役割を果たしており、特に器具のデザイン、使いやすさ、安全機能の革新が重要です。最新の骨内留置器具は、自動または半自動で展開するように設計されることが多くなっており、挿入に必要な熟練度を減らし、合併症のリスクを最小限に抑えています。これらの器具は現在、針刺し損傷を防ぎ、骨髄内に確実に留置するための安全機構を備えていることが多いです。さらに、材料と工学の進歩により、緊急時の過酷な使用にも耐えうる、より耐久性と信頼性の高い器具が開発されるようになった。このような技術革新により、骨髄内注入はより幅広いヘルスケア・プロバイダーにとって利用しやすくなり、病院前、病院、軍事環境での使用が拡大しています。

骨髄内注入装置の需要がヘルスケア現場で高まっている理由とは？

骨髄内注入装置の需要は、クリティカルケアにおける有効性が認識されつつあることや、医療従事者のトレーニングプログラムが拡大していることから、ヘルスケアの現場全体で高まっています。救急救命士、救急医、軍医など、より多くのヘルスケアプロバイダーが腹腔内デバイスの使用に関するトレーニングを受けているため、その採用はより広まりつつあります。この器具は、救急治療室や重症患者の搬送中など、循環系への迅速なアクセスが不可欠な場面で特に重宝されています。さらに、血管合併症を引き起こす可能性のある慢性疾患や病態の蔓延が、代替血管アクセス法の必要性を高めており、骨髄内注入装置の需要をさらに押し上げています。これらのデバイスの採用は、特定の緊急状況での使用を推奨する最新の臨床ガイドラインやプロトコルによっても支えられており、現代の医療現場における役割を強化しています。

骨髄内注入装置市場の成長を促進する要因は？

骨髄内注入装置市場の成長は、技術の進歩、アプリケーションの拡大、クリティカルケアにおける迅速なバスキュラーアクセスのニーズの高まりと密接に結びついたいくつかの要因によって牽引されています。主な促進要因の1つは、デバイス設計の進歩であり、これにより腹腔内注入がより簡単に、より安全に、より信頼できるものになった。このため、救急部、集中治療室、病院前ケアなど、さまざまなヘルスケア環境での採用が広がっています。また、外傷、心臓救急、その他の即座の血管アクセスを必要とする疾患の発生率が上昇していることも、従来の静脈アクセスが困難な場合に、これらのデバイスが迅速かつ効果的な代替手段を提供するため、市場の成長に拍車をかけています。さらに、緊急事態における患者の転帰を改善することへの注目の高まりと、ヘルスケア専門家向けのトレーニングの利用可能性が高まっていることも、市場を前進させています。こうした動向が進化を続ける中、骨髄内注入装置市場は、高度で信頼性が高く、迅速なバスキュラーアクセスソリューションに対するクリティカルケアシーンでのニーズに後押しされ、持続的な成長が見込まれています。

調査対象企業の例（全42件）

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP12828

Global Intraosseous Infusion Devices Market to Reach US$8.2 Billion by 2030

The global market for Intraosseous Infusion Devices estimated at US$5.4 Billion in the year 2023, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Automatic Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Manual Technology segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.8% CAGR

The Intraosseous Infusion Devices market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intraosseous Infusion Devices Market - Key Trends & Drivers Summarized

What Are Intraosseous Infusion Devices and Why Are They Critical in Emergency Medical Care?

Intraosseous infusion devices are specialized medical tools designed to deliver fluids, medications, and blood products directly into the bone marrow when traditional intravenous (IV) access is not feasible. These devices are critical in emergency medical care, particularly in situations where time is of the essence, such as during trauma, cardiac arrest, or shock, where patients may have collapsed veins or other conditions that make IV access difficult. Intraosseous infusion provides a rapid, reliable, and effective alternative for vascular access, ensuring that lifesaving treatments can be administered quickly. The use of these devices is growing, especially in emergency rooms, intensive care units, and military settings, where immediate vascular access can significantly impact patient outcomes.

How Are Technological Advancements Shaping the Intraosseous Infusion Devices Market?

Technological advancements are playing a significant role in shaping the intraosseous infusion devices market, particularly through innovations in device design, ease of use, and safety features. Modern intraosseous devices are increasingly being designed for automatic or semi-automatic deployment, which reduces the skill level required for insertion and minimizes the risk of complications. These devices now often feature safety mechanisms to prevent needle-stick injuries and to ensure secure placement within the bone marrow. Additionally, advancements in materials and engineering have led to the development of more durable and reliable devices that can withstand the rigors of emergency use. These innovations are making intraosseous infusion more accessible to a broader range of healthcare providers, thereby expanding its use in pre-hospital, hospital, and military environments.

Why Is There an Increasing Demand for Intraosseous Infusion Devices Across Healthcare Settings?

The demand for intraosseous infusion devices is increasing across healthcare settings due to the growing recognition of their effectiveness in critical care situations and the expanding training programs for healthcare professionals. As more healthcare providers, including paramedics, emergency physicians, and military medics, are trained in the use of intraosseous devices, their adoption is becoming more widespread. The devices are particularly valued in settings where rapid access to the circulatory system is essential, such as in emergency rooms and during transport of critically ill patients. Additionally, the increasing prevalence of chronic diseases and conditions that can lead to vascular complications is driving the need for alternative vascular access methods, further boosting demand for intraosseous infusion devices. The adoption of these devices is also supported by updated clinical guidelines and protocols that recommend their use in specific emergency situations, reinforcing their role in modern medical practice.

What Factors Are Driving the Growth in the Intraosseous Infusion Devices Market?

The growth in the intraosseous infusion devices market is driven by several factors closely tied to technological advancements, expanding applications, and the increasing need for rapid vascular access in critical care. One of the primary drivers is the advancement in device design, which has made intraosseous infusion easier to perform, safer, and more reliable. This has led to broader adoption across various healthcare settings, including emergency departments, intensive care units, and pre-hospital care. The rising incidence of trauma, cardiac emergencies, and other conditions requiring immediate vascular access is also fueling market growth, as these devices offer a fast and effective alternative when traditional IV access is challenging. Additionally, the growing focus on improving patient outcomes in emergency situations, along with the increasing availability of training for healthcare professionals, is driving the market forward. As these trends continue to evolve, the intraosseous infusion devices market is expected to experience sustained growth, driven by the need for advanced, reliable, and rapid vascular access solutions in critical care scenarios.

Select Competitors (Total 42 Featured) -

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraosseous Infusion Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Rapid Access in Emergency Medicine Spurs Adoption of Intraosseous Infusion Devices
    • Advancements in Device Technology Propel Innovation in Intraosseous Infusion
    • Shift Towards Minimally Invasive Emergency Procedures Expands Market Opportunities
    • Increasing Adoption of Intraosseous Infusion in Pediatric and Geriatric Patients
    • Role of Intraosseous Devices in Military and Disaster Medicine
    • Growing Importance of Immediate Vascular Access in Critical Care
    • Expansion of Pre-Hospital Care Drives Demand for Portable Intraosseous Devices
    • Emerging Markets Present New Opportunities for Intraosseous Device Manufacturers
    • Push for Cost-Effective and Easy-to-Use Infusion Solutions
    • Role of Intraosseous Devices in Enhancing Survival Rates in Trauma Cases
    • Integration of Intraosseous Infusion Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Sternum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Distal & Proximal Tibia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Distal Femur by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Calcaneus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Head of Humerus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Automatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for EMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Cardiac Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Intraosseous Infusion Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION